Med Ed Report briefs

Skyscape and the Massachusetts Medical Society are partnering to offer a mobile version of Journal Watch, MMS's medical-literature summary service. All 13 specialty versions of Journal Watch will be available in mobile, and the program will support eight different platforms, including iPhone/iPad, Android, BlackBerry and Palm.

The Institute for Healthcare Improvement and VHA became the first two institutions to receive a new joint accreditation from three accrediting bodies: the Accreditation Council for CME, the Accreditation Council for Pharmacy Education and the American Nurses Credentialing Center.

Physicians World Speakers Bureau hired Cindi DaRin as VP for operations. She had worked for Health Learning Systems, as SVP, operations and staffing. DaRin will lead teams supporting existing and future clients on PW's proprietary speakers' bureau workflow app and oversee meetings management and registration services groups.

ReachMD, a 24/7 education network whose CME broadcasts play on live satellite radio, won an MM&M Gold Award for Best Healthcare Professional Media Brand at the seventh annual MM&M Awards in New York last month.

Commenting on NIH's proposed COI rules, the American Society of Clinical Oncology (ASCO) said researchers should not have to report travel reimbursement as payment and that the NIH's definition of the word “manage” should be changed to include disclosure of the COI as an acceptable management strategy. NIH issued its proposed COI rewrite last May.
You must be a registered member of MMM to post a comment.

Next Article in Features

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters

Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.